13F-HR filed by Springhill Fund Asset Management (HK) Co Ltd
Springhill Fund Asset Management (HK) Co Ltd filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 19 holding rows worth $20,867,368.
- Accession
- 0001911270-25-000003
- Filer
- CIK 1911270
- Filed
- 2025-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 19 entries on the cover page, a total value of $20,867,368 stated on the cover page (in dollars after the unit check, H1), rows summing to $20,867,368 with VALUE read as dollars as filed, 13F file number 028-25005. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 63,499 | $4,031,552 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 124,307 | $2,397,882 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 78,500 | $2,119,500 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 2,600 | $1,648,998 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 13,612 | $1,505,487 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 19,192 | $1,464,158 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 19,858 | $1,418,854 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 9,853 | $1,223,250 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 19,925 | $806,564 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,146 | $678,277 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 816 | $673,943 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 12,859 | $621,861 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 13,500 | $532,305 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 7,076 | $363,494 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,173 | $338,684 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 6,277 | $332,493 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 3,000 | $273,180 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 5,897 | $260,235 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 29,491 | $176,651 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001911270-25-000003 | this filing | 2025-05-14 | acceptance time not in the bulk data set |